Stockreport

Translate Bio Announces First Quarter 2019 Financial Results and Provides Corporate Update

Telesis Bio, Inc.  (TBIO) 
PDF -- Completed dosing in single-ascending dose portion of Phase 1/2 clinical trial in cystic fibrosis; data expected 3Q19 -- LEXINGTON, Mass., May 09, 2019 (GLOBE NEWSW [Read more]